FORM 4 ý
Check
this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
|
OMB APPROVAL |
OMB
Number: 3235-0287 |
1. Name and Address of Reporting Person *
(Last)
(First)
(Middle)
(Street)
(City)
(State) (Zip)
|
2. Issuer Name and Ticker Liberty Media Corporation
3. I.R.S.
Identification |
4. Statement for April 3, 2003
|
6. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director
Officer (give title below)
X 10% Owner
Other (specify below) Chairman of the Board
|
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security |
2. Transaction Date
(Month/Day/ |
2A. Deemed Execution Date,
if any (Month/Day/ |
3. Transaction Code |
4. Securities Acquired (A)
or Disposed of (D) |
5. Amount of Securities
Beneficially Owned Following Reported Transaction(s) |
6. Ownership Form: Direct
(D) or Indirect (I) |
7. Nature of Indirect
Beneficial Ownership |
|||
Code |
V |
Amount |
(A) or (D) |
Price |
||||||
Series B Common Stock |
4/3/03 |
|
J(1) |
V |
15,488,310 |
D(1) |
$10.185 |
9,511,690(2) |
D |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table II Derivative Securities Acquired, Disposed of, or
Beneficially Owned |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security |
3. Transaction Date |
3A. Deemed Execution Date,
if any (Month/Day/ |
4. Transaction Code (Instr. 8) |
5. Number of Derivative
Securities Acquired (A) or Disposed of (D) |
6. Date Exercisable and
Expiration Date |
7. Title and Amount of
Underlying Securities |
8. Price of Derivative
Security |
9. Number of Derivative
Securities Beneficially Owned Following Reported Transaction(s) |
10. Ownership Form of
Derivative Securities: Direct (D) or Indirect (I) |
11. Nature of Indirect
Beneficial Ownership |
||||
Code |
V |
(A) |
(D) |
Date |
Expiration |
Title |
Amount or Number of Shares |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Explanation
of Responses: (1) On April 3, 2003, the Reporting Person distributed to Dr. John Malone, as an annuity payment, 15,488,310 shares of Series B Common Stock, representing $157,748,434 in market value (based on the average of the high and the low sale price of such shares on April 3, 2003). The transfer of Series B Common Stock by the Reporting Person to Dr. Malone may be deemed to be a change in the form of beneficial ownership of the transferred shares by Dr. Malone. (2) Pursuant to a call agreement between the Issuer and Dr. John Malone and his spouse, the Issuer has the right, under certain circumstances, to acquire Series B Common Stock owned by Dr. Malone and his spouse and their permitted transferees. The shares owned by the Reporting Person are subject to that right.
|
/s/ Malone GRAT #2 by David Thomas III, Trustee ** Signature of Reporting Person |
April 4, 2003 Date |
Reminder: Report on a separate line for each
class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements
or omissions of facts constitute Federal Criminal Violations.
See 18
U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
http://www.sec.gov/divisions/corpfin/forms/form4.htm
Last update: 09/05/2002